Anthem Blue Cross Settlement $8,850 Over Brand Name Drug Denials
The Anthem Blue Cross Settlement $8,850 Over Brand Name Drug Denials settlement to eligible claimants who the person was covered by an anthem blue cross life and health insurance co. health plan at any time between jan. 1, 2017, and may 8, 2026.. The deadline to file is November 10, 2026. Proof of purchase is required.
Deadline: November 10, 2026
Total amount allocated for all claims
Estimated amount per eligible claim
Submit a completed claim form with documentation for each drug listed: (1) a copy of the prescription or written verification from the prescribing provider or dispensing pharmacy; and (2) proof the claimant personally paid out of pocket, such as a pharmacy receipt, credit card statement, or cancelled check. For online claims, provide the unique claimant ID and access code from the settlement notice. The administrator will reject incomplete claims; if documentation is missing, the claimant typically receives one opportunity to submit supplemental information, otherwise the claim is denied.
Settlement Summary
This class action settlement centers on a dispute between California regulators and Anthem Blue Cross Life and Health Insurance Co. over whether Anthem properly covered “grandfathered” health insurance plans—policies that were allowed to keep certain older terms under California law. According to the California Department of Insurance, some members with these grandfathered plans were denied medically necessary brand-name, single-source prescription drugs solely because they were brand-name products, even though the prescription would otherwise have been covered. For many consumers, those denials meant paying out of pocket, and in some cases Anthem also imposed an $8,850 deductible related to brand-name drug coverage, adding significant financial pressure for patients who needed specific medications. The lawsuit was filed because the alleged denials and deductible charges conflicted with requirements in California’s insurance regulations governing how these grandfathered plans must treat certain drug coverage decisions. Instead of fighting the allegations to an evidentiary hearing, Anthem agreed to settle by reimbursing eligible policyholders for their out-of-pocket costs for brand-name (single-source) drugs denied for that specific reason, and by issuing refunds for qualifying members who paid part or all of the $8,850 deductible. Claims are limited to specific Anthem plan types during a defined window (Jan. 1, 2017 to May 8, 2026), require proof of the prescription and payment, and must be submitted by individuals who were not reimbursed by other insurers or parties—so the case is significant as a direct consumer remedy tied to alleged noncompliance rather than a broader change in clinical outcomes. Broader implications extend beyond a single insurer because the settlement highlights how “brand vs. generic” coverage rules, prior coverage protections, and deductible structures can materially affect patients, especially when regulators believe insurers are enforcing restrictions inconsistently with state requirements. Similar disputes have repeatedly arisen across the health insurance industry—often involving contract terms, formulary practices, and consumer protections—when consumers argue that insurers are effectively pricing them out of medically necessary drugs. Overall, this case illustrates the regulatory pressure on insurers to adhere to state law for grandfathered plans and to justify coverage denials in a way that aligns with California’s oversight of health benefits, making it a notable example of enforcement translating into consumer reimbursements for denied brand-name medications
Entities Involved
Related Topics
Eligibility Requirements
- The person was covered by an Anthem Blue Cross Life and Health Insurance Co. health plan at any time between Jan. 1, 2017, and May 8, 2026.
- Coverage was under one of these specified plans: Core 5000, Tonik DN14, Tonik DN15, or RightPlan (with generic prescription drug coverage).
- The person personally paid out of pocket for a brand name (single-source) prescription drug during the class period.
- The health plan would have covered the prescription, but Anthem denied coverage solely because the drug was a brand name (single-source) product.
- No other health plan or third party reimbursed the person for the out-of-pocket costs.
- A separate claim form is required for each individual (family members cannot combine expenses on a single form).
- Claims must include required documentation; incomplete claims may be denied after one opportunity to submit supplemental information.
Featured Investigations
Important Notice About Filing Claims
Submitting false information in a settlement claim is considered perjury and will result in your claim being rejected. Fraudulent claims harm legitimate class members and may result in legal consequences.
If you are unsure about your eligibility for this settlement, please visit the official settlement administrator’s website using the link provided above. Review the eligibility criteria carefully before submitting a claim.
Class Action Champion is an independent information resource and is not affiliated with any settlement administrator, law firm, or court. We provide settlement information as a service to help connect eligible class members with legitimate settlements.